In Brief
The epicardium, the outermost cell layer of the heart, contains progenitors that contribute to non-cardiomyocytes. How epicardial progenitors transition to a mature cell type is unknown. Xiao et al. demonstrate that Hippo kinases Lats1/2 promote epicardial-fibroblast transition, which is essential for maintaining proper extracellular milieu and coronary vessel development.
INTRODUCTION
The epicardium, cells covering the outer layer of the heart, originates from the extra-cardiac proepicardium. The proepicardium is compartmentalized into populations that give rise to cardiac endothelium and mesenchymal cells: fibroblasts and smooth muscle (Katz et al., 2012; Acharya et al., 2012) . At mouse embryonic day 9.5 (E9.5), proepicardial cells attach to myocardium, spread as a continuous epithelial sheet, and form a single cell layer covering the entire myocardium. The epicardium expresses a number of important genes including signaling molecules such as retinaldehyde dehydrogenase 2 (Raldh2), and genes encoding transcription factors: Wilms' tumor 1 (Wt1), transcription factor 21 (Tcf21), T-box18 (Tbx18), and multiple C/EBP transcription factor family members (Acharya et al., 2012; Cai et al., 2008; Guadix et al., 2011; Huang et al., 2012; Zhou et al., 2008) .
A subset of epicardial cells delaminate, undergo epithelialmesenchymal transition (EMT) and generate epicardial-derived cells (EPDCs). In mammals, EPDCs emanating from Wt1-expressing lineage primarily give rise to vascular smooth muscle cells and fibroblasts, two supporting cell types that are important for coronary vascular and myocardial development. EPDCs first populate the subepicardial space between epicardium and myocardium, forming the subepicardial mesenchyme, and invade the myocardium where they differentiate into supporting cells of the heart (Wessels and Perez-Pomares, 2004) .
Although adult epicardial cells are quiescent, they are activated upon injury and contribute to the repair process by expressing developmental programs in the injured adult heart Huang et al., 2012; Lepilina et al., 2006) . Activated adult epicardium is a source of pro-inflammatory signals after myocardial infarction. In the adult heart C/EBP factors activate pro-inflammatory signals after injury whereas Yap and Taz, two Hippo pathway effectors, promote anti-inflammatory response to injury Ramjee et al., 2017) .
The Hippo signaling pathway, an organ size control pathway, inhibits cell proliferation and promotes apoptosis (Halder and Johnson, 2011) . Hippo pathway components include ste-20 family kinases Mst1 and Mst2 (Mst1/2), which complex with scaffold adaptor protein Salvador (Sav) to phosphorylate the nuclear dbf2-related (NDR) family kinases Lats1 and Lats2 (Lats1/2). Yap and Taz are transcriptional co-factors that are substrates for Lats1/2 kinases. Upon phosphorylation by Lats1/2 kinases, Yap and Taz are excluded from the nucleus and transcriptional activity is inhibited. Removing Hippo pathway components in embryonic or adult myocardium releases the downstream effector Yap from Hippo-dependent suppression, promoting cardiomyocyte (CM) proliferation and tissue regeneration (Heallen et al., 2011 (Heallen et al., , 2013 Morikawa et al., 2015) .
We used single-cell transcriptomics to investigate Lats1/2 function in epicardial progenitor cell diversification. A highthroughput single-cell RNA-sequencing (RNA-seq) platform, Drop-seq, was adopted to characterize E13.5 and E14.5 cardiac cellular composition and heterogeneity in Lats1/2-deficient and control hearts (Macosko et al., 2015) . Our data revealed that Lats1/2 activity is required for EPDC progression from a transient subepicardial mesenchyme to fully differentiated cardiac fibroblasts, and provide insight into mechanisms coordinating fibroblast development with coronary vascular remodeling in heart development.
RESULTS

Epicardial Deletion of Lats1/2 Results in Defective Coronary Vessel Development
We deleted Lats1/2 in E11.5 epicardium using the Wt1 CreERT2 allele (Zhou et al., 2008) . Lats1/2 conditional knockout (CKO) embryos failed to survive past E15.5 ( Figure S1A ). Lats1/2 CKO E14.5 hearts appeared normal (Figures S1B and S1C), but E15.5 mutant hearts were smaller, with less compacted myocardium (Figures 1A and S1B) . Lats1/2 CKO embryos also displayed skin hemorrhages, as well as herniated livers and intestines (Figures S1D-S1F).
E14.5 to E15.5 is a critical stage for coronary vessel morphogenesis when the vascular plexus remodels to meet increased oxygen demands (Red-Horse et al., 2010; Viragh and Challice, 1981) . Pecam-1 immunostaining in E14.5 Lats1/2 CKO hearts revealed reduced vessel coverage and density with blood island-like structures ( Figure 1B ). Pecam-1 immunofluorescence (IF) staining with confocal microscopy and automated quantification revealed that dorsal vasculature had decreased branching and reduced vessel coverage with fewer junctions and increased lacunarity (Figures 1C and 1D) . As controls, we injected tamoxifen to Wt1
CreERT2/+ embryos and Cre-negative littermates and injected vehicle (peanut oil) to Wt1 CreERT2 ; Lats1/2 f/f and Cre-negative littermates. Coronary vessel development in controls was normal (Figures S2A and S2B) .
We examined Yap subcellular localization and Yap phosphorylation (p-Yap) as a readout of Lats kinase activity. Yap localization in Lats1/2 CKO hearts, detected by total Yap and podoplanin IF, revealed increased nuclear Yap in both epicardium and subepicardium ( Figures 1E and 1F) . IF revealed decreased p-Yap in Lats1/2 CKO epicardium and subepicardium but no change in CMs, since we inactivated Lats 1/2 in the epicardial lineage ( Figure 1G ). Podoplanin, restricted to the epicardium in control embryos, was also expressed in Lats1/2 CKO subepicardium, suggesting that EMT occurred prior to repression of the epicardial program ( Figure 1G ).
Recent work indicated that epicardial deletion of Yap and Taz led to defective EMT (Singh et al., 2016) . In situ hybridization with EMT markers revealed that Snai2 was elevated in Lats1/2 CKO hearts, while Twist1 was unchanged (Figures S2C and S2D) . Transforming growth factor b (Tgfb) signaling that promotes epicardial EMT (Sridurongrit et al., 2008) was elevated in Lats1/2 CKO epicardium as determined by increased nuclear p-Smad2/3, a readout of Tgfb signaling (Figures S2E and S2F) .
To Figures 1H and 1I ).
Unbiased Single-Cell Transcriptomics of E13.5 and E14.5 Embryonic Hearts We used Drop-seq to profile cardiac tissue from control and Lats1/2 CKO E13.5 and E14.5 embryos, the stages preceding the Lats1/2 CKO cardiac phenotype. Graph-based clustering was performed on significant principal components identifying 28 distinct clusters and results visualized through a non-linear dimensional reduction algorithm, t-distributed stochastic neighbor embedding (tSNE) (Maaten and Hinton, 2008; Macosko et al., 2015) . We acquired 18,757 cells in total across two time points and two genotypes that was reduced to 18,166 single cells after subtracting red blood cells and platelets (cluster 16) (Figures 2A-2C ). Differential expression analysis on spatially proximal clusters revealed transcriptionally well-defined clusters. (A) E15.5 histology showed reduced compacted myocardium in Lats1/2 CKO. Panels on the right are high-magnification views of boxed area in panels on the left. Scale bars, 400 mm (left panels) and 80 mm (right panels).
(B) Coronary vessels visualized by Pecam-1 at E14.5. Lats1/2 CKO had decreased vessel coverage (asterisks) and blood islands (arrows) on ventral and lateral heart. Scale bars, 500 mm. Figures 2E and 2F ). We evaluated nonepicardial-derived lineages, specifically CMs and endothelial cells. Analysis of E13.5-E14.5 heart tissue, excluding the atria, revealed a cellular composition that was distinct from adult murine cardiac tissue that is made up of approximately 31% CMs and 43% endothelial cells (Pinto et al., 2016) . Our results indicated that E13.5-E14.5 murine heart contains 43% CMs and only 19% endothelial cells ( Figure 2E ). CMs and endothelial cells were heterogeneous and were further subcategorized ( Figures 2E and 2F ). The two rarest CM populations were atrioventricular canal (AVC) and trabecular CMs. AVC CMs were identified based on a molecular signature that included the Wnt-pathway gene Rspo3 and the Bmppathway gene Bmp2 ( Figures 2F, S3A , and S3B) (Cambier et al., 2014; Ma et al., 2005) . In addition to Rspo3 and Bmp2, we detected other AVC CM markers, including Pitx2, Shox2, Wisp1, Tbx2, Tbx3, Tbx5, and Bmp7 (Campione et al., 2001; Habets et al., 2002) (Figure S3B ). Trabecular CMs were identified by a signature that included Nppa and Gja5 ( Figures 2F and S3B ) (Jensen et al., 2012) . Further clustering revealed several known and novel CM markers, as well as proliferating CM signatures ( Figure S3B ) .
Endothelial cell subcategories included vascular endothelial cells that were distinguishable by Fabp4 and Apln expression ( Figure S3C ) (He et al., 2014; Liu et al., 2015) . Arterial endothelial cells were identified by markers, including Gja5, Fbln2, Fbln5, and Sox17 (Figures 2F and S3C) (Liu et al., 2015) . Endocardial cells were characterized by high levels of Npr3 (Zhang et al., 2016) in addition to markers not previously associated with endocardium including Ednrb, Adgrg6, Plvap, and Smoc1 (Figures 2F and S3C) . In valvular endocardium, we discovered three distinct clusters of Nfatc1-positive cells (EndoV1 to EndoV3) revealing an unappreciated heterogeneity ( Figure S3D ). The EndoV3 cluster displayed high expression of endocardial-tomesenchymal transition (EndoMT)-associated genes Enpp2, Prox1, and Fzd10 ( Figures S3C-S3F ), suggesting that dynamic phenotypic changes that characterize EndoMT may add to valvular endocardial heterogeneity (Gong et al., 2014; Lu et al., 2012; Shaul et al., 2014 (Liebner et al., 2004; Bosada et al., 2016) . Valve mesenchyme expresses Sfrp2, a Wnt inhibitor (Cruciat and Niehrs, 2013) , suggesting a mechanism to downregulate Wnt in mesenchymal cell maturation ( Figures  S3E and S3F ). We noted heterogeneous expression across valve endocardial clusters of aquaporin (AQP) genes (e.g., Aqp8 and Aqp1) that encode water channel proteins and control cellular osmotic balance. AQPs have not been implicated in valve development (Figures S3E and S3F) (Rutkovskiy et al., 2013 ).
An Epicardial-Derived Population Composed Primarily of Lats1/2-Deficient Cells We compared relative proportions of cell types in control and Lats1/2 CKO hearts ( Figure 2F ). Although we saw differences in a few non-epicardial-derived cell types, such as macrophages and trabeculated myocardium, we focused on the epicardial lineage. Two clusters showed statistically significant enrichment in Lats1/2 CKO hearts compared with control (chi-squared test, p < 0.0025). One of these was the epicardial cluster, which suggested increased proliferation and self-renewal or defective differentiation of Lats1/2 CKO epicardium. The second predominantly Lats 1/2 mutant cluster, designated cluster 20 (C20), possessed a gene signature intermediate between that of fibroblasts and epicardium. C20 cells expressed Tcf21, a marker of epicardial cells and resting fibroblasts and Col11a1 ( Figure 2F ) (Acharya et al., 2012) . Cells that had a transcriptional signature similar to that of C20 cells were also observed in control hearts at lower frequency than Lats1/2 CKO hearts, and IF data revealed that these cells, localized to the subepicardial space, represent subepicardial mesenchyme (see below). Because IF experiments uncovered important differences in protein expression between control and Lats 1/2 CKO subepicardial cells (see below), we will refer to the subepicardial-like cells in Lats 1/2 CKO hearts as C20 cells and in control as subepicardial Figure S3 . mesenchyme cells. We also observed a reduction in cardiac fibroblasts in E14.5 Lats1/2 CKO hearts, suggesting a defect in epicardial-to-fibroblast transition ( Figure 2F ).
We used iterative clustering to investigate the transcriptional distinctions between cell populations in more depth. We included vascular endothelial cells (VECs) in our analysis given the Lats 1/2 CKO defective coronary vessel phenotype ( Figures  3A-3C ). We identified an additional fibroblast-like subtype, FB2, expressing multiple pericyte markers including Rgs5, Cspg4 (Ng2), Kcnj8, and Pdgfrb ( Figures 3C and S4A ) (Armulik et al., 2011) . Pericytes are precursors of epicardial-derived smooth muscle (Volz et al., 2015) . Importantly, the C20 and subepicardial mesenchyme transcriptional signature resembled that of fibroblasts with epicardial features, but was distinct from Fabp4-expressing VECs ( Figures 3C and 3D ). C20 cells and subepicardial mesenchyme expressed a subset of fibroblast markers such as Col1a1 and Spon2, but were deficient for mature fibroblast markers, such as Postn and Sox9 ( Figures  3C and 3D ). C20 and subepicardial mesenchyme also expressed epicardial genes such as Wt1 and Aldh1a2, Dpp4, Smoc2, and Alcam, but failed to express Upk3a and Upk3b that mark mesothelium ( Figures 3C and 3D ) (Rudat et al., 2014) . Other genes, not normally expressed in epicardium or fibroblasts, were uniquely enriched in C20 and subepicardial mesenchyme, such as Ephb2 and Vgll3, indicating that C20 and subepicardial mesenchyme have a distinctive signature while sharing similarity with epicardium and cardiac fibroblasts. The subclustering also revealed that C20 and subepicardial mesenchyme were homogeneous and represented an intermediate population between epicardium and fibroblasts ( Figure 3B ). Together, the Drop-seq data showed accumulation of epicardial and C20 cells in Lats 1/2 CKO hearts with a concomitant reduction in differentiated cardiac fibroblasts, suggesting that Lats1/2 are required for progression of the normal developmental transition from epicardium to fibroblasts.
Pseudotime Analysis Revealed Defective Epicardial Cell Transitions in Lats 1/2 CKO Hearts
To investigate epicardial developmental dynamics, we used Monocle2 to order cells along a developmental axis progressing from epicardial cells to cardiac fibroblasts (Qiu et al., 2017) . Importantly, pseudotime ordering matched closely with the graph-based clustering results (Figures 3E [top] and 3F). The leftmost portion of the epicardial cluster represents the most primitive cellular state and the bottom right section the most differentiated cellular state ( Figure 3E , bottom). C20, and a few control subepicardial mesenchyme cells, were isolated centrally along this differentiation axis, supporting the notion that C20 is a transition-state intermediate between epicardial progenitors and differentiated fibroblasts ( Figure 3G , top).
Cells diverging from the Monocle2 minimum spanning tree (MST) were captured as alternative trajectories by their connection to the full MST path through nodes that represent developmental junctions where cell-fate decisions are made (Trapnell et al., 2014) . We identified a node ( Figure 3G , top, node X) proximal to final bifurcation of cardiac fibroblasts (Figure 3G, top, branch A) and C20 population ( Figure 3G , top, branch B) revealing two distinct EPDC differentiation paths. The ''branch A'' trace, composed primarily of control cells (Figure 3E, top) , revealed a normal EPDC-to-fibroblast differentiation trajectory and cellular transition from epicardial cells to mature fibroblasts. In contrast, the ''branch B'' trace, comprised predominantly of Lats1/2 CKO mutant C20 cells ( Figure 3E , top), revealed a cell type that was intermediate between epicardial cells and fibroblasts, indicating that most Lats1/2 CKO cells failed to progress to fully differentiated cardiac fibroblasts.
To identify genes expressed in the node X bifurcation, we examined gene expression patterns across pseudotime and uncovered several co-varying expression patterns. The first expression pattern, characteristic of branch A fibroblast differentiation had a higher expression level in differentiated fibroblasts ( Figure 3G , bottom, upper three tracks-branch A). The second expression pattern was typical of the C20 population found in branch B ( Figure 3G , bottom, lower three tracks-branch B). Gene ontology (GO) analysis of branch B genes revealed GO terms including extracellular matrix (ECM) and blood vessel development, suggesting that genes expressed by C20 cells contributed to the coronary vessel remodeling defects observed in Lats1/2 CKO hearts ( Figure 3H ). The enriched GO term ECM included collagen genes and genes that are essential for collagen processing including SerpinH1 and Plod2, which have also been implicated in human osteogenesis imperfecta syndromes (Table S1 ) (Ito and Nagata, 2017; Puig-Hervas et al., 2012) . In addition, genes encoding growth factors, such as Bmp4 and Edn1 that modulate ECM composition in multiple contexts, were also in the branch B category (Hathaway et al., 2015; Salazar et al., 2016) (Table S1 and Figure 3K ). It has been shown that collagen density regulates proper angiogenesis by modulating the balance between endothelial cell migration and proliferation. An excessive amount of collagen suppresses vessel sprouting (Shamloo et al., 2016) . Other ECM genes in branch B, such as Cyr61 and Ptn (Table S1 and Figure 3K ), are matricellular proteins that promote endothelial cell proliferation (Fang et al., 1992; Hanna et al., 2009; Hinkel et al., 2014) . Dpp4, encoding a membrane bound protease, is another ECM gene that is also in the GO category ''Protein digestion and absorption'' (Table S1 ). Dpp4 proteolyzes both ECM and matrix-embedded growth factors to modulate endothelial cell migration (Ghersi et al., 2006) . Taken together, Hippo inhibits a gene program that controls multiple aspects of ECM composition, which affects vessel development including endothelial cell proliferation, migration, and vessel branching.
Cluster 20-Enriched Genes Are Direct Yap-Tead Targets
To determine whether C20-and subepicardial mesenchymeexpressed genes were direct Yap-Tead targets, we performed unbiased transcription factor DNA-binding motif enrichment analysis across a 20-kb region centered on the transcription start site of each branch B gene. Srf and Tead elements were the most enriched motifs in branch B ( Figure 3I ). While Tead was highly expressed in C20 and subepicardial mesenchyme, Srf was lowly expressed, suggesting that most branch B genes were directly regulated by Yap-Tead ( Figure 3I ). Tead1 expression was enriched throughout C20 and subepicardial mesenchyme and its expression level decreased, moving across pseudotime from C20 and subepicardial mesenchyme toward differentiated fibroblasts ( Figure 3J ). Conversely, Sox9 was low in epicardial cells and C20 and subepicardial mesenchyme but high in cardiac fibroblasts ( Figure 3J ). Enriched GO terms among branch B Yap-Tead direct target genes included ECM organization, regulation of cell migration, and blood vessel development ( Figures 3H and 3K ). Other direct Yap-Tead target genes in C20 and subepicardial mesenchyme were not included in a specific GO category, such as Dhrs3, encoding an enzyme that reduces retinoic acid levels ( Figure 3K ) (Billings et al., 2013) . Other Yap-Tead targets expressed in C20 and subepicardial mesenchyme included Sfrp1, encoding a Wnt antagonist, Lbh, implicated in human congenital heart disease, and Cnn2, encoding an actin-binding protein that regulates directed cell migration (McKean et al., 2016; Nusse and Clevers, 2017; Ulmer et al., 2013) .
The C20 Cluster Resides in Subepicardial Space
To validate our Drop-seq findings and obtain spatial information about C20, we performed IF experiments based on known epicardial markers and newly identified genes expressed in C20. Podoplanin and keratin expression, markers of the singlecell layer epicardium, both expanded into Lats1/2 CKO subepicardium, indicating that the Lats1/2 CKO mutant C20 cells still maintained epicardial characteristics that were not observed in control subepicardial mesenchyme ( Figures 4A, 4B , and S4B) (Acharya et al., 2012) . Platelet-derived growth factor receptor a (PDGFR-a), a marker of fibroblasts and subepicardial mesenchyme, was expressed in a single cell layer within E14.5 control subepicardium, while in Lats1/2 CKO embryos PDGFR-a was expressed in a several-layer-thick subepicardium containing C20 cells ( Figures 4C and 4D) . Likewise, Wt1, a marker for epicardium and subepicardium, was expressed in Lats1/2 CKO epicardium and C20 cells within the subepicardial space ( Figure 4E ) (Rudat and Kispert, 2012) . Similarly, Dpp4, Col1a1, and Alcam, expressed in both epicardium and subepicardium in control embryos, were expressed in epicardium and C20 cells in Lats1/2 CKO hearts ( Figures 4F-4H and S4C ). Spon2 displayed a different expression pattern by IF ( Figure S4D ) compared with its transcriptional expression ( Figure 3C ). In Lats 1/2 CKO epicardium, Spon2 was restricted to Lats 1/2 CKO epicardium, suggesting that post-transcriptional mechanisms inhibit Spon2 protein expression in C20 and subepicardial mesenchyme. Together, the IF data support the conclusion that the C20 population normally resides in subepicardium and that Lats1/2 deficiency results in increased numbers of C20 cells in the subepicardial space.
Lats1/2 Epicardial Deficiency Results in Diminished Cardiac Fibroblast Differentiation
Experiments using Rosa26 mTmG reporter to lineage trace epicardial-derived lineages revealed that Lats1/2 CKO hearts showed abundant GFP-positive cells in myocardium, indicating that EPDC entered the myocardium ( Figure S5A ). EdU (5-ethynyl-2 0 -deoxyuridine) labeling indicated that Wt1 CreERT2 lineagederived epicardial cells and EPDCs were more proliferative in Lats1/2 CKO embryos than in controls ( Figures S5B and S5C ). Proliferation genes were not enriched upon GO analysis of branch B, suggesting that proliferation was not the main distinguishing feature between C20 and cardiac fibroblasts (Figure 3H ). Concurrent labeling of the Wt1 CreERT2 lineage with Rosa26 mTmG and PDGFR-a to mark cardiac fibroblasts, revealed by both IF and fluorescence-activated cell sorting (FACS) a reduction in epicardial-derived fibroblasts from 44% to 32% in Figure 4 . C20 Is Located in Subepicardium and Expands in Lats1/2 CKO Hearts (A and B) Podoplanin labels epicardium (white arrows) and a-actinin labels myocardium. The intervening region is subepicardium, and Lats1/2 CKO showed expanded subpicardium weakly stained by podoplanin (yellow arrows). Quantification is shown in (B).
(C and D) PDGFR-a rarely labels epicardium (white arrows) and extensively labels subepicardium (yellow arrows). Lats1/2 CKO hearts had thickened PDGFR-a-positive subepicardium.
(E-G) Wt1 (E), Dpp4 (F), and collagen I (G) labels epicardium (white arrows) and subepicardium (yellow arrows) in Lats1/2 CKO hearts. Lats1/2 CKO hearts had expanded Wt1-positive subepicardium.
Data represent means ± SD; *p < 0.1, Mann-Whitney U test (B and H). Scale bars, 25 mm (A, C, and E-G). See also Figure S4 .
Lats1/2 CKO mutants compared with controls ( Figures 5A-5C ). IF with vimentin, another cardiac fibroblast marker, confirmed the reduction of epicardial-derived fibroblasts ( Figures 5D  and 5E ). Together, the lineage-tracing data further supported the Drop-seq results, demonstrating that inactivation of Lats1/2 led to defective epicardial differentiation into mature cardiac fibroblasts.
We examined coronary artery smooth muscle differentiation. Smooth muscle myosin heavy chain IF in E15.5 Lats1/2 CKO embryos revealed that coronary arteries established an aortic connection in Lats1/2 CKO embryos and were invested with neural crest-derived smooth muscle ( Figure S6A ) (Jiang et al., 2000) . PDGFR-b IF combined with lineage tracing uncovered a reduction of E14.5 epicardial-derived smooth muscle cell progenitors, suggesting that the smooth muscle lineage differentiation from epicardium was diminished in Lats1/2 CKO hearts. The IF data were consistent with reduction in FB2 pericyte smooth muscle progenitors observed in Drop-seq data ( Figures S6B-S6D ) (Volz et al., 2015) .
Yap Coordinately Regulates Fibroblast Differentiation and Coronary Vessel Remodeling
To investigate in more depth whether genes expressed in C20 and subepicardial mesenchyme are direct Yap target genes, we compared embryonic heart H3K27ac data with cardiac DNase-sequencing (DNase I-hypersensitive site [DHS]) data and extracted TEAD motifs from the E14.5 H3K27ac peaks (GSE52386). Several consensus TEAD motifs, Yap-binding sites, were identified at enhancer and promoter regions of genes enriched in branch B, such as Ogn, Spon2, Gpc3, and Alcam (Figures S7A and S7B) . Consensus Tead motifs were also found in Dpp4 and Dhrs3. We performed Yap chromatin immunoprecipitation combined with qPCR at Tead motifs contained within H3K27ac and DHS peaks using the MEC1 epicardial cell line to determine whether Yap directly bound to these loci. In the Dpp4 and Dhrs3 loci, Yap showed specific binding ( Figures S7B and S7C) .
Dhrs3 was upregulated in Lats 1/2 CKO hearts, which may contribute to impaired fibroblast differentiation by reducing retinoic acid formation and signaling (Billings et al., 2013) . Retinoic acid was suggested to play a role in EPDC differentiation into fibroblasts (Braitsch et al., 2012) . We used a Dhrs3 À/À mouse model that had elevated retinoic acid signaling to examine cardiac fibroblast differentiation using PDGFR-a + IF (Billings et al., 2013) . We observed more PDGFR-a-expressing fibroblasts in Dhrs3 À/À myocardium compared with controls, supporting the hypothesis that Dhrs3 upregulation, as a downstream Yap target, led to reduction in retinoic acid signaling and promoted fibroblast differentiation arrest in Lat1/2 CKO hearts ( Figures  6A and 6B ). We treated Lats1/2 CKO embryos and controls with the Dpp4 inhibitor sitagliptin (Choy and Lam, 2007) . Pecam IF and automated quantification revealed that sitagliptin treatment partially suppressed the disorganized coronary vessel in Lats1/2 CKO hearts ( Figures 6C-6E ). While some blood islands still appeared on the ventral side of sitagliptin-treated Lats1/2 CKO hearts, the dorsal side lacked blood islands ( Figure 6C) . Moreover, the dorsal-side vessel coverage phenotype was also suppressed in sitagliptin-treated Lats1/2 CKO hearts when compared with untreated Lats1/2 CKO hearts (compare Figures 1B and 1C with Figures 6C and 6D) . Pecam-1 IF also revealed that defects of vessel percentage area and mean lacunarity were suppressed by Dpp4 inhibition (Figures 6D and 6E ), supporting our model that Lat1/2 CKO coronary vessel defects were partially caused by elevated Dpp4 activity.
Mechanical Signaling Regulates Hippo Activity in Epicardial Cells
Mechanical tension is an upstream physiologic regulator of Hippo/Yap activity (Dupont et al., 2011) . To examine mechanical tension in epicardial differentiation, we cultured Wt1-expressing primary epicardial cells on hydrogels of different stiffness (Figure S7D) . Primary epicardial cells cultured on 4-kPa matrix, approximating embryonic heart stiffness (Majkut et al., 2013) , exhibited a spindle shape with Yap distributing equally to nucleus and cytoplasm ( Figure 6F ). In contrast, epicardial cells grown on a stiffer 20-kPa matrix had a flat shape with increased nuclear Yap localization ( Figure 6F ). Interestingly, spindle-shaped cells strongly expressed the fibroblast marker PDGFR-a while flatshaped cells were weakly positive for PDGFR-a ( Figures 6G  and 6H ). These data suggest that mechanical tension is an upstream physiologic signal controlling Hippo/Yap activity in epicardial cells and that increased nuclear Yap, perhaps resulting from elevated mechanical tension, impedes epicardial-cell to fibroblast transition.
DISCUSSION
We uncovered an essential role for the Hippo pathway kinases, Lats1/2, in promoting the transition from epicardial progenitors into differentiated cardiac fibroblasts while concurrently controlling ECM composition and vascular remodeling (Figure 7) . Hippo signaling promotes retinoid signaling by inhibiting a negative regulator of retinoid signaling, Dhrs3, enhancing subepicardial mesenchyme to cardiac fibroblast differentiation. Our data suggest that the subepicardial transition state may be responsive to specific physiologic cues, mediated through the Hippo pathway, that modulate genes encoding matricellular factors such as Dpp4 that control ECM characteristics and vascular remodeling (Figure 7 ). Our data represent the first in vivo characterization of a transition state at the single-cell level in the heart.
Lats1/2 Regulate Epicardial Progenitor Differentiation into Cardiac Fibroblasts
We discovered an autonomous function for Hippo signaling in promoting differentiation of cardiac fibroblasts. Lats1/2 inhibit Dhrs3, a Yap target gene and a negative modulator of retinoic acid signaling, as subepicardial cells differentiate into cardiac fibroblasts. Our data are consistent with previous findings showing that retinoid signaling is required for cardiac fibroblast differentiation and epicardial EMT (Braitsch et al., 2012; Wang et al., 2018) . We found that Dhrs3 mutant embryos had more cardiac fibroblasts. Little is known about the interaction of retinoic acid signaling with the Hippo pathway. In an in vitro model of neural crest development, in contrast to our findings Yap synergizes with retinoids to promote the neural crest phenotype, suggesting context-dependent modifiers of Yap and retinoid interactions (Hindley et al., 2016) .
Cluster 20, a Cell Intermediate between Epicardium and Cardiac Fibroblasts
In Lats1/2 CKO hearts, we discovered an expansion of C20, a cell type with characteristics of both epicardium and primitive cardiac fibroblasts. Importantly, Drop-seq revealed that C20 was found in both wild-type and mutant hearts, indicating that C20 is a transition cell related to subepicardial mesenchyme, which exists during normal epicardial diversification. Furthermore, IF validation revealed that C20 was located in the subepicardial space, supporting the hypothesis that C20 is closely related to subepicardial cells. IF experiments also revealed that cells in the Lats 1/2 CKO subepicardial space, containing C20 cells, expressed podoplanin and keratin, which are restricted epicardial markers, indicating that C20, while closely related to control subepicardial cells, also had distinct epicardial characteristics (Acharya et al., 2012) ( Figures 4A and S4B) . The distinct podoplanin and keratin expression between Lats1/2 CKO C20 cells and control subepicardial cells was not detected by Drop-seq, suggesting that podoplanin and keratin expression was regulated post-transcriptionally or that their transcripts were below the level of detection for Drop-seq.
Hippo Signaling Coordinates Vascular Development with Fibroblast Differentiation
An important insight from our study, not previously appreciated, is the non-autonomous connection between cardiac fibroblast differentiation and vascular patterning. Our data suggest that the disorganized coronary vessel patterning in Lats1/2 CKO hearts is due to aberrant signaling from Lats1/2 mutant C20 cells. Importantly, we validated Dpp4 as a direct Yap target and found that Dpp4 inhibition partially suppressed the coronary vessel remodeling defect in Lats1/2 CKO hearts. Crosstalk, mediated by growth factors, between epicardium and myocardium is critical for coronary vessel angiogenesis and myocardium growth during heart development (Smart et al., 2011; Zhou et al., 2011) . Our data reveal a new interaction between developing fibroblasts that express matricellular factors that modulate ECM composition and control signaling to developing vasculature. The cell surface serine protease, Dpp4, and its direct inhibitor Gpc3 regulate multiple essential signaling events in coronary vascular development (Khurana et al., 2013; Ou et al., 2013) . Dpp4 controls the functional activity of chemokines and cytokines that contain Dpp4 proteolytic motifs. In the context of human cord blood, the chemokine Cxcl12 is cleaved by Dpp4 and inhibits the function of uncleaved Cxcl12 (Christopherson et al., 2002) . Recent data reveal that Cxcl12, signaling through Cxcr4, promotes endothelial cell migration and coronary plexus pruning and maturation (Cavallero et al., 2015; Harrison et al., 2015) . Our Dpp4 inhibitor findings also suggest that a prolonged C20 transition state results in more Dpp4 activity, resulting in endothelial remodeling defects.
Mechanical Tension Determines Cardiac Fibroblast Differentiation by Controlling Yap Activity
During heart development, organ vascularization is coordinated with overall heart size to meet growing cardiac metabolic needs. Our data suggest that the epicardium and subepicardium are important for coordinating organ vascularity with organ size. In other contexts, it has been shown that in addition to Hippo pathway kinases, mechanical tension acts as another mode of regulation of nuclear Yap activity (Dupont et al., 2011) . Our data, using primary epicardial cells, further reveal the importance of mechanical signaling in regulating Yap. A tempting model would be that with heart growth, a gradual tension increase in epicardium and subepicardium may transiently promote nuclear Yap activity and EMT with subepicardial cell proliferation and activation of Yap target genes. In this scenario, Hippo kinase activity may modify the influence of mechanical tension on EMT, proliferation, and differentiation so that the correct number of subepicardial cells and EPDCs are formed.
In addition to new insights into Hippo signaling in epicardial diversification, our data provide important insight into all developing cardiac cell types at E13.5-E14.5, including rare cell types such as macrophages and arterial endothelial cells. Along with other recently described datasets, our data will be useful for further investigation of CM and non-CM characteristics in both the developing and adult heart (DeLaughter et al., 2016; Skelly et al., 2018) .
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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Jiang, R., Lan, Y., Norton, C.R., Sundberg, J.P., and Gridley, T. (1998). The Slug gene is not essential for mesoderm or neural crest development in mice. Dev. Biol. 198, Li, G., Xu, A., Sim, S., Priest, J.R., Tian, X., Khan, T., Quertermous, T., Zhou, B., Tsao, P.S., Quake, S.R., et al. (2016) Figure S2A ). Batch effects were corrected for and principle components analysis was carried out. Cells were dissociated as previously described (Dyer and Patterson, 2013) . Hearts were chopped into several pieces and digested by 1mg/ml collagenase I for 20 min at 37 C. Every 10min, the sample was gently pipetted sample up and down to mechanically dissociate the cells. 10% FBS in DMEM was applied to quench the protease, and samples were passed through a 100mm strainer. Following tissue dissociation cells were diluted to a concentration of 150,000 cells/mL in PBS with 0.1% BSA. Next, Drop-seq was performed according to Macosko et. al (Macosko et al., 2015) . Briefly, cells were co-encapsulated into nano-liter sized droplets containing barcoded microparticles and lysis buffer using a Drop-seq specific microfluidics device (custom made by FlowJEM, Toronto, Canada). After droplet breakage, reverse transcription, and exonuclease treatment, total cDNA was amplified, pooled, and purified with Ampure XP beads and then quality control, quantification and size determination was performed using a Fragment analyzer (Advanced Analytical Technologies, Inc.) for quality control, quantification, and size determination. Tagmentation and library preparation was performed with the Illumina Nextera XT kit. Final libraries were triple purified with a successive Ampure XP based protocol, whereby two successive 0.6X (beads to sample ratio) purifications were performed, followed by a final 1X purification step. All libraries were sequenced on an Illumina Nextseq500 instrument.
Drop-seq Data Analysis
Sequencing data was processed as described in Shekhar et. al. (2016) (Macosko et al., 2015; Shekhar et al., 2016) . Briefly, raw fastq files were converted to BAMs with Picard tools (MergeSamFiles) and then used as input for STAR alignment (Dobin et al., 2013) , cell barcode correction, and digital gene expression (DGE) matrix generation via the Drop-seq tools software package (available at http:// mccarrolllab.com/dropseq/). Next, DGEs from each experiment were merged. We then imported the comprehensive DGE into Seurat (version 1.4.0.5) where normalization was performed according to package default settings . Batch effects were corrected for with the application of Combat, from the R SVA package (version 3.18.0), and by further regressing out the number of molecules per cell and the percentage of mapped mitochondrial reads with the RegressOut function (Seurat package) (Leek et al., 2012) . Next, principle components analysis was performed and significant PCs were used as input for graph-based clustering. Finally, 2-dimesnsional visualization of the multi-dimensional data set was done with tSNE (Maaten and Hinton, 2008) . Differential expression of the various clusters was also performed with Seurat, using the likelihood-ratio test for single cell gene expression (McDavid et al., 2013) . For iterative clustering, cell barcodes were selected from each cell type and deposited into a new digital expression matrix prior to principle component analysis (PCA), graph based clustering, and tSNE visualization. We evaluated these cell types and performed differential expression analysis (likelihood-ratio test for single cell gene expression (McDavid et al., 2013) .For pseudotime analysis, the normalized data from the indicated clusters calculated in Seurat was then passed directly into Monocle2 (Qiu et al., 2017) . The Monocle2 branched expression analysis modeling (BEAM) statistical test was utilized to isolate the branch-specific gene expression patterns (256 genes with qval <0.1). Motif enrichment analysis was carried out with the Cytoscape plug-in iRegulon using the mouse genome's default parameters (Janky et al., 2014) . All gene ontology (GO) analysis was performed with the Metascape tool (http://metascape.org) (Tripathi et al., 2015) .
Histology and Immunofluorescence
Epicardium-restricted-Lats1/2 mutant embryos (Lats1/2 CKO) were generated by crossing Wt1
CreERT2 with Lats1/2 f/f or Lats1/2 f/f ; Rosa26 mTmG . Control embryos were generated by crossing Wt1 CreERT2 with Rosa26 mTmG or Cre negative littermate control. For H&E staining and immunofluorescence staining, hearts were fixed in 4% PFA overnight at 4 C and dehydrated in a serial ethanol, xylene and embedded in paraffin. Sections of 7mm thick sections were stained with H&E for histological analyses (Singhal and Martin, 2015) . For some immunofluorescence staining, cryosections were used. Antibodies used for immunofluorescence staining were as follows: GFP ( Signal Amplification Systems (1:100, Perkin Elmer) were used to amplify signal. PECAM-1 whole mount staining was performed as previously described (Mukouyama et al., 2012) . PECAM-1(1:100) staining was followed either by anti-rat-HRP (1:200, Life Technologies, 62-9520) and a DAB kit (Vector lab) for color development or anti-rat-Alexa-647 for immunofluorescence staining. The vessel pattern was quantified by Angiotool.
RNA In Situ Hybridization
The tissues for RNA in-situ hybridization were prepared as described above except adding Diethylpyrocarbonate (DEPC) was added to avoid RNAse contamination. RNA in-situ hybridization was performed by the RNA In Situ Hybridization Core at Baylor College of Medicine. The Twist1 (Ma et al., 2005) and Snai2 (Jiang et al., 1998) probes were previously described.
QUANTIFICATION AND STATISTICAL ANALYSIS
Images taken by Nikon A1-Rs inverted laser scanning microscope were process with FIJI software. Contrast and image size of IF images were adjusted with Adobe photoshop CC or GIMP. Images of Drop-seq were produced in R. Flow cytometry graphs were generated by FlowJo. Bar graphs were generated by GraphPad Prism 6. All figures were made in Adobe Illustrator CC 2015 or Canvas X or Inkscape. Coronary vessel pattern was analyzed by AngioTool. Statistical analyses were performed in SPSS 21.0. Sample size was labelled on the corresponding bar graph, otherwise n=3 in all groups, which represent the number of hearts were analyzed in each experimental group. N number of cell composition in Drop-seq( Figure 2F ) and FACS analysis ( Figure 5C ) indicated number of cells were analyzed. For IF images, three fields of views were analyzed in each heart. For quantification of PDGFR-a cells Figure 6A , percentage of PDGFR-a was calculated by PDGFR-a + cell number was divided by total cell number in compact myocardium. For quantification of pSmad2/3 high in Figures S2E and 6F , in each experimental group, epicardial cells from 2-4 different hearts were analyzed and counted as total observation number. Mann-Whitney U test were used for most studies, except the cell composition in Dropseq( Figure 2F ), FACS analysis ( Figure 5C ), and pSmad2/3 high cells in epicardium, in which Chi-square were used. The cut-off value for statistical significance were indicated in corresponding figure legend.
DATA AND SOFTWARE AVAILABILITY
The Drop-seq dataset has been deposited in Gene Expression Omnibus (GEO) with accession number GEO: GSE100861.
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